KDIGO guidelines include FILSPARI for IgA nephropathy treatment
Go back to KDIGO guidelines include FILSPARI for IgA nephropathy treatment| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 336.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $336.04 | 52 Week High | $114.49 | |||
| Open | $336.04 | 52 Week Low | $75.17 | |||
| Day High | $336.04 | P/E | 93.09 | |||
| Day Low | $336.04 | EPS | $3.61 | |||
| Volume | 1,248 | |||||
| (AMEX: CSLLY) | Delayed: 20.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.00 | 52 Week High | $45.60 | |||
| Open | $20.00 | 52 Week Low | $33.39 | |||
| Day High | $20.00 | P/E | N/A | |||
| Day Low | $20.00 | EPS | $0.00 | |||
| Volume | 19 | |||||
| (NASDAQ: TVTX) | Delayed: 57.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.36 | 52 Week High | $ | |||
| Open | $57.36 | 52 Week Low | $ | |||
| Day High | $57.36 | P/E | N/A | |||
| Day Low | $57.36 | EPS | $ | |||
| Volume | 30 | |||||

